Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 7.5% on Analyst Downgrade
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) fell 7.5% on Tuesday after Scotiabank lowered their price target on the stock from $52.00 to $51.00. Scotiabank currently has a sector outperform rating on the stock. Rocket Pharmaceuticals traded as low as $6.65 and last traded at $6.48. 484,777 shares changed hands during mid-day […]
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) fell 7.5% on Tuesday after Scotiabank lowered their price target on the stock from $52.00 to $51.00. Scotiabank currently has a sector outperform rating on the stock. Rocket Pharmaceuticals traded as low as $6.65 and last traded at $6.48. 484,777 shares changed hands during mid-day […]
